BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2007
View Archived Issues
Snapshots of clinical trials in cardiology
Read More
Orally bioavailable anthracycline penetrates the CNS in mice
Read More
Novel agents for HIV infection reported in recent Pfizer patent
Read More
Ccr2 protective in Alzheimer's disease
Read More
Genetic studies allow creation of test for clozapine-induced agranulocytosis risk
Read More
Clevudine metabolism studied in human hepatocytes
Read More
New therapeutic options for hepatitis C described in recent patent literature
Read More
Novel therapeutic agents for neurological disorders reported in recent patents
Read More
Cerus presents preclinical data on two new L. monocytogenes-based immunotherapeutics
Read More
Further analysis of CRD5 phase I/II data
Read More
ACE and NMRC begin Campylobacter challenge study
Read More
Syndax licenses selective HDAC inhibitor from Bayer Schering Pharma
Read More
Thallion updates progress of FDA Advisory Committee meeting on STEC infection
Read More
Galapagos signs new collaborations with Ono
Read More
AGI receives FDA approval for phase III study of arverapamil
Read More
Bayer and WHO sign agreement for Lampit provision for Chagas disease
Read More
MultiCell signs supply agreement with Lundbeck
Read More
Pevion and Mymetics sign virosome technology license agreement
Read More
TopoTarget to acquire Apoxis
Read More
Multikinase inhibitor from Amgen with antiangiogenic and antitumor activity
Read More
LY-2401401, a new multikinase inhibitor, presented at the AACR meeting
Read More
VEGFR inhibitor with potent antitumor activity alone and in combination
Read More
Novel series of substituted pyrroles shows promise for the treatment of breast cancer
Read More
Eisai completes Morphotek acquisition
Read More
Renvela meets primary endpoint in hyperphosphatemic patients
Read More
BNC-105, a vascular disruption agent with an improved therapeutic index
Read More
Merck seeks new indications for Gardasil for vaginal and vulvar cancers
Read More
Once-weekly formulation of risedronate sodium approved in Japan
Read More
Avastin approved in Japan for advanced or recurrent colorectal cancer
Read More
Reclast approved for Paget's disease
Read More